STAT Plus: 3 drug pricing policy experiments to watch in 2020
HYACINTH EMPINADO/STAT
Drug pricing issues to watch in 2020: Several states will try to eliminate hepatitis C. Others will try to end insulin rationing, or take aim at PBMs.
Suscribirse a:
Enviar comentarios (Atom)
.png)
No hay comentarios:
Publicar un comentario